Eukaryotic initiation factor 6 (eIF6), an essential protein important in ribosome biosynthesis and assembly, was identified as an interacting partner of the b-catenin C terminus in the yeast two-hybrid assay. Independent studies identified Drosophila eIF6 (DeIF6) in a genetic screen designed to detect new genes involved in the regulation of the Wnt/Wg (wingless) pathway. Ectopic expression of DeIF6 in wing discs results in a Wg phenotype. Expression of eIF6 in adenomatous polyposis coli (APC)-mutant colon cancer cells, which express high levels of active b-catenin, showed that eIF6 selectively inhibits the Wnt pathway at the level of b-catenin protein independently of proteasomal degradation. Incorporation of radiolabeled amino acids into b-catenin was selectively decreased in cells that overexpressed eIF6. A similar inverse relationship of the two proteins was observed in the APC min/ þ mouse intestine, in which b-catenin levels are very high. Taken together these data reveal a link between eIF6 and Wnt signaling, perhaps at the level of ribosome recycling on b-catenin mRNA.
Introduction
Several studies have highlighted the role of ribosome biogenesis and function in cell transformation (Ruggero and Sonenberg, 2005) . For example, changes in the level and/or activity of eukaryotic initiation factors 2 and 4 (eIF2 and eIF4) are often associated with transformation, and the Wnt/b-catenin target gene myc regulates the synthesis of ribosomal RNAs (Clemens, 2004; Arabi et al., 2005) . Although eIF6 was named because of its homology to translational initiation factors, it does not play a direct role in the initiation of protein translation (Si and Maitra, 1999) . eIF6 is essential for biogenesis of the 60S ribosome and must be released before proper assembly of 40S and 60S subunits can take place (Sanvito et al., 1999; Wood et al., 1999; Basu et al., 2001) . In the cytoplasm, eIF6 is phosphorylated through the RACK1-PKCbII pathway and released from the 60S subunit, thus allowing the assembly of 40S and 60S subunits into the 80S ribosome (Ceci et al., 2003) . In addition, casein kinase 1 (CK1) phosphorylation of eIF6 regulates its nucleocytoplasmic localization and mutant inactive eIF6 is constitutively nuclear suggesting that it has an important role in the cytoplasm (Basu et al., 2003) . eIF6 also interacts with integrin-b4 (Biffo et al., 1997) .
b-Catenin is important in cell adhesion and is a key molecule in the canonical Wnt signaling pathway. In the absence of Wnts, b-catenin is constitutively phosphorylated by CK1 and glycogen synthase kinase 3b (GSK3b) at the N terminus (Rubinfeld et al., 1996; Orford et al., 1997) . This occurs while b-catenin is associated with APC (adenomatous polyposis coli), Axin, protein phosphatase 2A and b-TrCP. Phosphorylated b-catenin is recognized by the ubiquitin ligase b-TrCP, leading to its ubiquitination and degradation by the proteasome (Hart et al., 1999; Kitagawa et al., 1999; Winston et al., 1999) . In the presence of Wnts, GSK3b activity is inhibited and the unphosphorylated form of b-catenin accumulates and translocates to the nucleus, where it activates the T-cell factor (TCF) family of transcription factors (Brantjes et al., 2002) , and gene transcription (Polakis, 1999; Bienz, 2005; Harris and Peifer, 2005) . Oncogenes such as c-Myc, PPARd and cyclin D 1 are targets of the Wnt/b-catenin pathway (He et al., 1998 (He et al., , 1999 Tetsu and McCormick, 1999) . In the present study we demonstrate that eIF6 regulates the Wnt pathway at the level of b-catenin protein.
Results
Ectopic expression of DeIF6 in the Drosophila wing margin generates a wingless phenotype We identified Drosophila eIF6 (DeIF6) in a genetic screen designed to identify new genes involved in the regulation of the Wnt/Wg (wingless) pathway. The screen was previously described (Haerry et al., 1997) but modified slightly for this study (see Supplementary Material). One of the point mutants, P2917, which is a P-element transposon insertion that disrupts the DeIF6 gene, was isolated from the screen as a modifier of Wg signaling. To further test the genetic interaction, ectopic DeIF6 expression experiments were performed. The fulllength DeIF6 cDNA was cloned into a standard fly upstream-activating sequence (UAS) expression vector and microinjected into fly embryos to make transformants. These transformants were crossed to a strain carrying the C96 GAL4 driver, which expresses GAL4 strongly in the future wing margin during larval and pupal stages. Both transformed strains had normal wings, while the progeny of the cross exhibited a wing-notching phenotype typical of wingless mutations and identical to that observed with genes that interact with armadillo (the Drosophila form of b-catenin; Figure 1 ) (Greaves et al., 1999) . These data demonstrate that overexpression of DeIF6 inhibits the Wg pathway.
eIF6 interacts with the C-terminus domain of b-catenin In an independent study, we identified eIF6 as an interactor of the b-catenin C-terminus domain (CTD). The b-gal activity for yeast cells containing both the CTD of b-catenin and eIF6 is markedly higher than negative controls such as CTD alone or library plasmids alone ( Figure 1B ), which suggests that eIF6 and The C terminus of b-catenin was cloned into pGBD vector and used as bait to screen a human mammary gland yeast two-hybrid library. The b-galactosidase activity of yeast containing both the CTD of b-catenin and eIF6 plasmids, which were obtained either from yeast mating or cotransfection, is significantly higher than negative controls. Enzyme units are defined as the relative enzyme activity (measured enzyme activity divided by the amount of plasmids used in transfection). eIF6, eukaryotic initiation factor 6; DeIF6, Drosophila eIF6.
b-catenin C terminus specifically interact with each other in the yeast two-hybrid system. On some occasions we were able to specifically co-precipitate eIF6 and b-catenin (Supplementary Material and Figure S1 ) but results of these experiments were not consistent, indicating that the interaction between these two proteins is transient or depends on the status of the cell.
The C-terminus region of eIF6 is required for inhibition of b-catenin signaling Activation of the canonical Wnt/Wg pathway results in the stabilization of b-catenin and its subsequent translocation to the nucleus where it acts as a coactivator for TCF to in turn activate Wnt/Wg target genes (Bienz, 2005; Harris and Peifer, 2005) . Consistent with a role for eIF6 as an inhibitor of Wnt/Wg signaling, we found that expression of eIF6 in 293 cells caused a dose-dependent decrease in activity of the b-catenin/ TCF responsive reporter, TOPFlash, but not of its mutated counterpart, FOPFlash (not shown) or renilla luciferase ( Figure 2a ). As 293 cells were co-transfected with b-catenin to activate TOPFlash, these data confirm that the inhibitory effect of eIF6 must either be at the level of b-catenin protein itself or downstream. TOPFlash analysis in SW480 cells transfected with full-length, N-terminus and C-terminus eIF6 constructs demonstrates that the C-but not N terminus of eIF6 is required to inhibit b-catenin transactivity ( Figure 2b ).
eIF6 selectively regulates b-catenin protein levels
We next wanted to study the mechanism whereby eIF6 inhibits Wnt/Wg signaling. As the C-terminus eIF6 interaction domain of b-catenin is required for its transactivation properties, we anticipated that the effects of eIF6 may be due to direct inhibition of b-catenin/TCF-mediated transcription. On the other hand, eIF6 is known to regulate ribosome assembly and could conceivably interfere with b-catenin translation and protein levels. Alternatively, eIF6 could have a new role in the targeting of specific proteins for degradation. The polyclonal antibody against the C terminus of eIF6 detects a specific 27 kDa band in immunoblot, which matches the predicted size of eIF6 (Biffo et al., 1997) . However this antibody only recognizes eIF6 in the nucleolus ( Figure 3a ) when used in immunocytochemistry, whereas immunoblot analysis demonstrates that the major fraction of eIF6 is actually in the cytoplasm (Ceci et al., 2003) . We reasoned that the epitopes detected by the eIF6 antibody were masked in the cytoplasm when detected by immunocytochemistry, but were available in the denatured protein detected by western blot. To more faithfully examine the distribution pattern of eIF6, an EYFP tag was cloned in-frame at the C terminus of eIF6. EYFP-eIF6 not only shows nucleolar distribution that recapitulates the polyclonal antibody-staining pattern but also shows cytoplasmic staining that is consistent with the western blot results (Figure 3a) . Therefore, the distribution pattern of YFP-eIF6 detected by fluorescence microscopy is closer to the normal distribution pattern of endogenous eIF6 protein than that detected by the antibody raised against eIF6 itself. In addition, we were able to co-precipitate YFP-eIF6 with its natural partner RACK1, which suggests that YFP-eIF6 is a functional protein in vivo (not shown). SW480 cells, an APC mutant colon cancer cell line with stabilized endogenous b-catenin, were used to study the distribution patterns of YFP-eIF6 and endogenous b-catenin. SW480 cells were transfected with YFP-eIF6 and labeled with anti-bcatenin antibody. Cells that were untransfected (B30%) exhibited intense b-catenin staining in the cytoplasm and nucleus, whereas b-catenin levels in cells that expressed YFP-eIF6 (B70%) were greatly reduced ( Figure 2a) . No change was observed in histone 2A. This relationship was confirmed by western analysis, which showed that the protein level of activated (Figures 3c and 4B ). These data demonstrate that the effects of eIF6 on Wnt/ Wg signaling and b-catenin transactivation are actually mediated by selective changes in the level of b-catenin protein.
eIF6 selectively regulates the incorporation of radiolabeled amino acids into b-catenin Since we did not find that b-catenin steady-state mRNA was decreased in cells overexpressing eIF6, we reasoned that the effects of eIF6 are a consequence of either a change in the rate of translation (mRNA recruitment to the ribosome or translational initiation, or post-initiation block) or protein degradation. However, the Figures 4A and B) . It should be noted that MG132 does not further increase endogenous b-catenin levels in APC-mutant cells such as SW480 cells, as the APC mutation essentially prevents its proteasomal degradation anyway. MG132 clearly blocked the degradation of b-catenin in Chinese hamster ovary (CHO) cells in a parallel experiment (Supplementary Material and Figure S2 ). In addition, we found that a dominant-negative form of the b-Trcp component of the ubiquitin ligase complex that targets b-catenin also failed to reverse the effects of eIF6 (Supplementary Material and Figure S2 ). We next tested the effects of elevated eIF6 on the rate of incorporation of radiolabeled amino acids into b-catenin protein. CHO cells were transfected with eIF6 and labeled with trans-mix ( 35 S-methionine, cysteine; 200 mCi/ml) for 2 h. In some experiments, the pulse was followed by a chase with non-radioactive methionine. A marked decrease in the amount of radioactive methionine incorporated into b-catenin but not IQGAP during the 2-h pulse occurred in cells transfected with YFPeIF6 compared to control cells ( Figure 4C, left panel) . A second experiment in which the cells were chased with cold methionine before immunoprecipitation showed that the decrease in incorporation persisted after the chase. Taken together with our immunocytochemistry and western analysis these data show that eIF6 selectively affects b-catenin protein synthesis.
Inverse relationship of b-catenin and eIF6 in the intestine of the APC min/ þ mouse In the APC min/ þ mouse, the presence of a truncated APC allele results in the stabilization of b-catenin and the development of intestinal polyps and adenomas independent of Wnt signaling (Goss and Groden, 2000) . If eIF6 were an endogenous inhibitor of the Wnt pathway at the level of b-catenin protein, we might expect to observe an inverse relationship between these two proteins in the APC min/ þ mouse. To test this hypothesis, serial sections of APC min/ þ mouse intestine were labeled with anti-b-catenin and anti-eIF6 antibody, respectively. Figure 4D shows a striking inverse relationship between the protein levels of b-catenin and eIF6 in adenomatous regions and the adjacent normal tissue. b-Catenin accumulated in the cytoplasm and nucleus in adenomatous region, and less was detected in the adjacent regions containing normal goblet cells. In contrast, eIF6 staining was stronger in the nucleus of normal goblet cells than it was in cells in the adenomatous region. These data raise the intriguing possibility that elevated b-catenin may also affect eIF6 levels.
Discussion
High levels of activated b-catenin in the cytoplasm and nucleus accompany Wnt/Wg signaling and are present in most colon cancers and in several other neoplasms with mutations in the tumor suppressor gene APC or stabilizing mutations in b-catenin itself (Fodde et al., 2001; Kikuchi, 2003; Clevers, 2004) . In these instances, the oncogenic and developmental effects of b-catenin are mediated by a change in protein stability rather than alterations in its transcription or translation (Bienz, 2005; Harris and Peifer, 2005) . Indeed, b-catenin mRNA is thought to be ubiquitously expressed. Although eIF6 is also an essential gene that is important in the genesis and function of the ribosome, its levels vary considerably during development and in different tissues and even among different cells in the same tissues (Donadini et al., 2001) . Although the precise mechanism whereby eIF6 regulates b-catenin protein levels is not clear it is selective as the levels of several other proteins, including IQGAP, actin, tubulin, GAPDH, HSP70, histone 2A and eIF6 itself are not affected. During revision of this manuscript, a study was published that sheds light on the mechanism, whereby eIF6 selectively regulates the translation of certain mRNAs. Chendrimada et al. (2007) showed that eIF6 is associated with the RNA-induced silencing complex (RISC) and specifically represses the translation of certain mRNAs in Caenorhabditis elegans without an effect on general translation. The RISC, which contains the 60S ribosomal subunit and eIF6, inhibits protein translation by blocking initiation or ribosome recycling. Indeed several miRNA target sequences are present in both human and mouse b-catenin 3 0 UTRs (http://cbio.mskcc.org/cgi-bin/mirnaviewer/mirnaviewer.pl). The location of eIF6 interaction to the b-catenin C terminus adjacent to the 3 0 UTR raises the intriguing possibility that ribosome recycling on b-catenin mRNA may be linked to and inhibited by eIF6 binding to newly translated b-catenin protein. In the presence of a b-catenin, targeted miRNA such a transient nonproductive protein/mRNA/miRNA complex may then become part of the RISC. Taken together with genetic evidence that eIF6 regulates Wg signaling and that a reciprocal relationship exists in the intestine of the APC min/ þ mouse, these data suggest that not only does eIF6 affect Wnt/Wg signaling through b-catenin, b-catenin itself may play a role in the regulation of eIF6 function.
Materials and methods

cDNAs, cell lines and antibodies
Full-length eIF6 was cloned into the pEYFP-N1 vector inframe with a C-terminus EYFP tag. HA-CMV-eIF6 was cloned in the pCMV-Tag2A vector in-frame with the HA tag. All plasmids were sequenced to confer sequence fidelity. Santa Cruz, Santa Cruz, CA, USA, respectively). The antieIF6 antibody S13 was generated against a C-terminus peptide of eIF6 (Biffo et al., 1997) .
Generation of transgenic fly strains
Genetic interaction assays were performed using dsh
/ þ ) with developmental defects such as deleted or duplicated legs, antennae and deleted wings were further analysed and used as a starting point to isolated smaller deficiencies and eventually point mutations as modifiers of dsh w . The full-length DeIF6 cDNA was cloned into the pUAST P-element vector and microinjected into 30-to 60-min-old white embryos by standard methods. UAS-deIF6/ þ lines were crossed with C96-GAL4 flies to obtain UAS-deIF6/ þ ; C96-Gal4 flies.
Yeast two-hybrid assay The CTD of b-catenin was cloned into pGBKT7 vector (Clontech, Mountain View, CA, USA) and used as bait in the screen of a human mammary gland yeast two-hybrid library (Clontech). Putative positive clones were further analysed and validated by either co-transforming DNA-BD/bait and AD/ library plasmids into AH109 yeast cells or performing yeast mating following the Matchmaker Gal4 two-hybrid system 3 manual (Clontech).
Transfection, immunofluorescence and immunoblot
Cells were transfected with pEYFP-eIF6 plasmid using FuGENE 6 transfection kit (Roche, Basal, Switzerland) or Lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection, cells were fixed with 2% paraformaldehyde in phosphate-buffered saline (PBS). Immunocytochemistry and immunoblotting were carried out as described previously (Orford et al., 1997) .
TOPFlash reporter assay HEK293 cells were seeded at 10 5 cells/well in 12-well plates 24-48 h before transfection. Cells were transfected with b-catenin, TOPFlash reporter, HA-CMV-eIF6 and the thymidine kinase Renilla luciferase plasmid (Promega, Madison, WI, USA) to control for variation in transfection efficiency. After lysis, luciferase and renilla activities were measured on a standard luminometer using the Dual-Reagent Luciferase Assay kit (Promega). Each experiment was performed independently at least three times.
Immunohistochemistry
Sections of APC min/ þ mouse intestine tissue were obtained from the Histopathology and Tissue Shared Resource Core of the LCCC, Georgetown University. Immunohistochemistry for b-catenin and eIF6 was carried out as described previously ($$).
Pulse-chase analysis Cells transfected with YFP-eIF6 were pulse labeled with transmix ( 35 S-methionine, cysteine, 200 mCi/ml; Amersham Pharmacia, Piscataway, NJ, USA) for 2 h. Cells were collected and lysed in radioimmunoprecipitation assay buffer. On some occasions, cells were chased with cold methionine for 1 h. Equal amount of protein (400 mg) were subjected to immunoprecipitation with b-catenin or IQGAP antibody (Upstate). The resulting material was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel (4-20%), dried on gel dryer and exposed to autoradiography film (Denville Scientific, Metuchen, NJ, USA) for 1 week at À801C. To determine overall protein translation rates, lysate containing equal amounts of protein (10 mg) was precipitated by adding two volumes of ice-cold 20% trichloroacetic acid, incubating on ice for 20 min and spin at 18 300 g for 10 min to precipitate protein. The pellet was washed with 400 ml ice-cold ethanol and ether (1:1 v/v), spun again and supernatant was removed. The pellet was dried at room temperature for 20 min and resuspended in 200 ml PBS. One microliter of each reaction was used for scintillation assay.
